Oncology is predicted to be a major driver in laboratory testing in coming years (see TDR, March 15, 2004). That said, lung cancer may be the next high-profile target, joining breast and prostate cancers as a high-priority disease. Last month the Journal of the American Medical Association (JAMA) reported that lung cancer rates among women …
“May 17, 2004 Intelligence: Late Breaking Lab News” Read More »